Zkusit zdarma
Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

YMAB
Cena:
 
 
Valuace
70
Růst
53
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?

Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?

10:56 01-09-2025

After reaching an important support level, Y-mAbs Therapeutics, Inc. (YMAB) could be a good stock pi...

Y-MABS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB

Y-MABS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB

21:05 19-08-2025

NEW YORK CITY and NEW ORLEANS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisian...

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates

8:45 08-08-2025

Y-mAbs Therapeutics, Inc. (YMAB) came out with a quarterly loss of $0.07 per share versus the Zacks ...

Shareholder Alert: The Ademi Firm Investigates Whether Y-mAbs Therapeutics Inc. is Obtaining a Fair Price for its Public Shareholders

Shareholder Alert: The Ademi Firm Investigates Whether Y-mAbs Therapeutics Inc. is Obtaining a Fair Price for its Public Shareholders

8:22 08-08-2025

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Y-mAbs (NASDAQ: YMAB) for possible breac...

Y-mAbs (YMAB) Q2 Revenue Falls 14%

Y-mAbs (YMAB) Q2 Revenue Falls 14%

7:37 08-08-2025

Y-mAbs Therapeutics (YMAB), a biopharmaceutical company focused on developing and commercializing an...

Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments

Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments

6:35 08-08-2025

PRINCETON, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or ...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)

18:44 07-08-2025

NEW YORK , Aug. 7, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & As...

Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025

Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025

7:30 07-08-2025

PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or ...

YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains?

YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains?

10:51 06-08-2025

YmAbs Therapeutics (YMAB) saw its shares surge in the last session with trading volume being higher ...

Y-mAbs Therapeutics upgraded to Equal Weight from Underweight at Morgan Stanley

Y-mAbs Therapeutics upgraded to Equal Weight from Underweight at Morgan Stanley

16:49 05-08-2025

Morgan Stanley upgraded Y-mAbs Therapeutics to Equal Weight from Underweight with a price target of ...

Y-mAbs Therapeutics downgraded to Hold from Buy at Canaccord

Y-mAbs Therapeutics downgraded to Hold from Buy at Canaccord

16:49 05-08-2025

Canaccord downgraded Y-mAbs Therapeutics to Hold from Buy with a price target of $8.60, down from $2...

Y-mAbs Therapeutics downgraded to Perform from Outperform at Oppenheimer

Y-mAbs Therapeutics downgraded to Perform from Outperform at Oppenheimer

16:47 05-08-2025

Oppenheimer analyst Jeff Jones downgraded Y-mAbs Therapeutics without a price target to Perform from...

Y-mAbs Therapeutics downgraded to Hold from Buy at Brookline

Y-mAbs Therapeutics downgraded to Hold from Buy at Brookline

15:28 05-08-2025

Brookline analyst Kemp Dolliver downgraded Y-mAbs Therapeutics to Hold from Buy with an $8.60 price ...

Y-mAbs Therapeutics downgraded to Hold from Buy at Truist

Y-mAbs Therapeutics downgraded to Hold from Buy at Truist

15:26 05-08-2025

Truist downgraded Y-mAbs Therapeutics to Hold from Buy with a price target of $8.60, down from $14, ...

Shareholder Alert: The Ademi Firm investigates whether Y-mAbs Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

Shareholder Alert: The Ademi Firm investigates whether Y-mAbs Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

12:08 05-08-2025

MILWAUKEE , Aug. 5, 2025 /PRNewswire/ -- The Ademi Firm is investigating Y-mAbs (NASDAQ: YMAB) for p...

YMAB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Y-mAbs Therapeutics, Inc. Is Fair to Shareholders

YMAB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Y-mAbs Therapeutics, Inc. Is Fair to Shareholders

9:47 05-08-2025

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t...

SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics

SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics

8:30 05-08-2025

Acquisition to Include Naxitamab-gqgk DANYELZA ® ( Naxitamab-gqgk) , Further Broadening SERB's Rare...

YmAbs Therapeutics (YMAB) Upgraded to Buy: Here's What You Should Know

YmAbs Therapeutics (YMAB) Upgraded to Buy: Here's What You Should Know

13:00 24-07-2025

YmAbs Therapeutics (YMAB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism ab...

Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline

Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline

6:35 28-05-2025

PRINCETON, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or ...

Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting

Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting

10:00 26-05-2025

PRINCETON, N.J., May 26, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or ...

close

Y-MABS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF Y-MABS THERAPEUTICS, INC. - YMAB

19-08-2025
NEW YORK CITY AND NEW ORLEANS, AUG. 19, 2025 (GLOBE NEWSWIRE) -- FORMER ATTORNEY GENERAL OF LOUISIAN...
Více zde

SHAREHOLDER ALERT: THE ADEMI FIRM INVESTIGATES WHETHER Y-MABS THERAPEUTICS INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

08-08-2025
MILWAUKEE--(BUSINESS WIRE)--THE ADEMI FIRM IS INVESTIGATING Y-MABS (NASDAQ: YMAB) FOR POSSIBLE BREAC...
Více zde

Y-MABS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS

08-08-2025
PRINCETON, N.J., AUG. 08, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR ...
Více zde

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB)

07-08-2025
NEW YORK , AUG. 7, 2025 /PRNEWSWIRE/ -- CLASS ACTION ATTORNEY JUAN MONTEVERDE  WITH MONTEVERDE & AS...
Více zde

Y-MABS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF Y-MABS THERAPEUTICS, INC. - YMAB

07-08-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde

Y-MABS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTS ON AUGUST 8, 2025

07-08-2025
PRINCETON, N.J., AUG. 07, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR ...
Více zde

SHAREHOLDER ALERT: THE ADEMI FIRM INVESTIGATES WHETHER Y-MABS THERAPEUTICS INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

05-08-2025
MILWAUKEE , AUG. 5, 2025 /PRNEWSWIRE/ -- THE ADEMI FIRM IS INVESTIGATING Y-MABS (NASDAQ: YMAB) FOR P...
Více zde

YMAB STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF Y-MABS THERAPEUTICS, INC. IS FAIR TO SHAREHOLDERS

05-08-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

SERB PHARMACEUTICALS AGREES TO ACQUIRE Y-MABS THERAPEUTICS

05-08-2025
ACQUISITION TO INCLUDE NAXITAMAB-GQGK DANYELZA ® ( NAXITAMAB-GQGK) , FURTHER BROADENING SERB'S RARE...
Více zde

Y-MABS HOSTS VIRTUAL RADIOPHARMACEUTICAL R&D UPDATE HIGHLIGHTING CLINICAL PROGRESS AND EXPANDED PIPELINE

28-05-2025
PRINCETON, N.J., MAY 28, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR ...
Více zde

Y-MABS PRESENTS GD2-SADA PRIT TRIAL IN PROGRESS POSTER AT THE ADVANCES IN NEUROBLASTOMA RESEARCH MEETING

26-05-2025
PRINCETON, N.J., MAY 26, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR ...
Více zde

Y-MABS TO HOST VIRTUAL RADIOPHARMACEUTICAL R&D UPDATE ON MAY 28, 2025

13-05-2025
PRINCETON, N.J., MAY 13, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR ...
Více zde

Y-MABS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS

13-05-2025
PRINCETON, N.J., MAY 13, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR ...
Více zde

Y-MABS ANNOUNCES UPDATE TO NATIONAL COMPREHENSIVE CANCER NETWORK® (NCCN®) CLINICAL PRACTICE GUIDELINES IN ONCOLOGY FOR NEUROBLASTOMA TO INCLUDE NAXITAMAB-GQGK (DANYELZA®)

07-05-2025
PRINCETON, N.J., MAY 07, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR ...
Více zde

Y-MABS TO ANNOUNCE FIRST QUARTER 2025 FINANCIAL AND OPERATING RESULTS ON MAY 13, 2025

06-05-2025
PRINCETON, N.J., MAY 06, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR ...
Více zde

Y-MABS PRESENTS TRANSLATIONAL PHARMACOKINETICS OF CD38-SADA FROM PRETARGETED RIT PLATFORM AT 2025 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING

27-04-2025
NEW YORK, APRIL 27, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MA...
Více zde

Y-MABS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 CLINICAL TRIAL EVALUATING CD38-SADA PRE-TARGETED RADIOIMMUNOTHERAPY IN RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA

25-04-2025
NEW YORK, APRIL 25, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MA...
Více zde

Y-MABS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS

04-03-2025
REPORTED TOTAL REVENUES OF $26.5 MILLION FOR THE FOURTH QUARTER OF 2024 AND $87.7 MILLION FOR THE FU...
Více zde

Y-MABS ANNOUNCES PUBLICATION OF PHASE 2 INTERIM RESULTS IN NATURE COMMUNICATIONS

03-03-2025
NAXITAMAB DEMONSTRATED CLINICALLY MEANINGFUL EFFICACY WITH MANAGEABLE SAFETY IN PATIENTS WITH RELAPS...
Více zde

Y-MABS TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL AND OPERATING RESULTS ON MARCH 4, 2025

20-02-2025
NEW YORK, FEB. 20, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

Y-MABS TO PRESENT AT THE OPPENHEIMER 35ᵗʰ ANNUAL LIFE SCIENCES CONFERENCE

06-02-2025
NEW YORK, FEB. 06, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

Y-MABS PRESENTS TRANSLATIONAL PHARMACOKINETICS OF GD2-SADA FROM PRETARGETED RIT PLATFORM AT THE SNMMI MID-WINTER AND ACNM ANNUAL MEETING

31-01-2025
NEW YORK, JAN. 31, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

CORRECTING & REPLACING – Y-MABS PROVIDES STRATEGIC BUSINESS UPDATE AND 2025 PRIORITIES

10-01-2025
COMPANY ESTABLISHES TWO BUSINESS UNITS WITH GOAL OF ACCELERATING CLINICAL DEVELOPMENT OF ITS RADIOPH...
Více zde

Y-MABS APPOINTS EXPERIENCED COMMERCIAL LEADER AS HEAD OF DANYELZA BUSINESS UNIT

10-01-2025
NEW YORK, JAN. 10, 2025 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

Y-MABS PROVIDES STRATEGIC BUSINESS UPDATE AND 2025 PRIORITIES

10-01-2025
COMPANY ESTABLISHES TWO BUSINESS UNITS WITH GOAL OF ACCELERATING THE ADVANCEMENT OF ITS RADIOPHARMAC...
Více zde

Y-MABS TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

23-12-2024
NEW YORK, DEC. 23, 2024 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

Y-MABS PRESENTS SADA PLATFORM PRECLINICAL DATA AND TRIAL IN PROGRESS POSTERS AT THE 2024 AMERICAN SOCIETY HEMATOLOGY (ASH) ANNUAL MEETING

07-12-2024
NEW YORK, DEC. 07, 2024 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

Y-MABS TO PARTICIPATE AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE

27-11-2024
NEW YORK, NOV. 27, 2024 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

Y-MABS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS

08-11-2024
NEW YORK, NOV. 08, 2024 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

Y-MABS AND NOBELPHARMA ANNOUNCE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT FOR DANYELZA® (NAXITAMAB-GQGK) IN JAPAN

04-11-2024
NEW YORK, NOV. 04, 2024 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MAB...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-09-16 01:00:008-KStáhnout
2025-09-16 00:00:008-KStáhnout
2025-08-08 01:00:008-KStáhnout
2025-08-08 01:00:0010-QStáhnout
2025-08-08 00:00:008-KStáhnout
2025-08-08 00:00:0010-QStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 00:00:008-KStáhnout
2025-07-15 01:00:008-KStáhnout
2025-07-15 00:00:008-KStáhnout
2025-05-28 01:00:008-KStáhnout
2025-05-28 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-03-04 00:00:008-KStáhnout
2025-03-04 00:00:0010-KStáhnout
2025-03-03 23:00:008-KStáhnout
2025-03-03 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2024-11-08 00:00:008-KStáhnout
2024-11-08 00:00:0010-QStáhnout
2024-11-07 23:00:008-KStáhnout
2024-11-07 23:00:0010-QStáhnout
2024-11-04 00:00:008-KStáhnout
2024-11-03 23:00:008-KStáhnout
2024-09-20 01:00:008-KStáhnout
2024-09-20 00:00:008-KStáhnout
2024-09-17 01:00:008-KStáhnout
2024-09-17 00:00:008-KStáhnout
2024-08-12 01:00:008-KStáhnout
2024-08-12 01:00:0010-QStáhnout
2024-08-12 00:00:008-KStáhnout
2024-08-12 00:00:0010-QStáhnout
2024-07-19 01:00:008-KStáhnout
2024-07-19 00:00:008-KStáhnout
2024-07-01 01:00:008-KStáhnout
2024-07-01 00:00:008-KStáhnout
2024-06-28 01:00:008-KStáhnout
2024-06-28 00:00:008-KStáhnout
2024-06-13 01:00:008-KStáhnout
2024-06-13 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-04-29 01:00:008-KStáhnout
2024-04-29 00:00:008-KStáhnout
2024-03-14 00:00:008-KStáhnout
2024-03-13 23:00:008-KStáhnout
2024-03-04 00:00:008-KStáhnout
2024-03-03 23:00:008-KStáhnout
2024-02-29 00:00:008-KStáhnout
2024-02-29 00:00:0010-KStáhnout
2024-02-28 23:00:008-KStáhnout
2024-02-28 23:00:0010-KStáhnout
2024-01-09 00:00:008-KStáhnout
2024-01-08 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-13 00:00:0010-QStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-12 23:00:0010-QStáhnout
2023-10-18 01:00:008-KStáhnout
2023-10-18 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-26 01:00:008-KStáhnout
2023-05-26 00:00:008-KStáhnout
2023-05-23 01:00:008-KStáhnout
2023-05-23 00:00:008-KStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 01:00:0010-QStáhnout
2023-05-08 00:00:008-KStáhnout
2023-05-08 00:00:0010-QStáhnout
2023-04-18 01:00:008-KStáhnout
2023-04-18 00:00:008-KStáhnout
2023-04-05 01:00:008-KStáhnout
2023-04-05 00:00:008-KStáhnout
2023-03-30 01:00:008-KStáhnout
2023-03-30 01:00:0010-KStáhnout
2023-03-30 00:00:008-KStáhnout
2023-03-30 00:00:0010-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-02-02 00:00:008-KStáhnout
2023-02-01 23:00:008-KStáhnout
2023-01-04 00:00:008-KStáhnout
2023-01-03 23:00:008-KStáhnout
2022-12-21 00:00:008-KStáhnout
2022-12-20 23:00:008-KStáhnout
2022-12-16 00:00:008-KStáhnout
2022-12-15 23:00:008-KStáhnout
2022-12-14 00:00:008-KStáhnout
2022-12-13 23:00:008-KStáhnout
2022-12-08 00:00:008-KStáhnout
2022-12-07 23:00:008-KStáhnout
2022-12-02 00:00:008-KStáhnout
2022-12-01 23:00:008-KStáhnout
2022-11-07 00:00:008-KStáhnout
2022-11-07 00:00:0010-QStáhnout
2022-11-06 23:00:008-KStáhnout
2022-11-06 23:00:0010-QStáhnout
2022-10-28 01:00:008-KStáhnout
2022-10-28 00:00:008-KStáhnout
2022-10-03 01:00:008-KStáhnout
2022-10-03 00:00:008-KStáhnout
2022-09-26 01:00:008-KStáhnout
2022-09-26 00:00:008-KStáhnout
2022-09-02 01:00:008-KStáhnout
2022-09-02 00:00:008-KStáhnout
2022-08-30 01:00:008-KStáhnout
2022-08-30 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-07-12 01:00:008-KStáhnout
2022-07-12 00:00:008-KStáhnout
2022-06-13 01:00:008-KStáhnout
2022-06-13 00:00:008-KStáhnout
2022-06-02 01:00:008-KStáhnout
2022-06-02 00:00:008-KStáhnout
2022-05-31 01:00:008-KStáhnout
2022-05-31 00:00:008-KStáhnout
2022-05-26 01:00:008-KStáhnout
2022-05-26 00:00:008-KStáhnout
2022-05-19 01:00:008-KStáhnout
2022-05-19 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-04-27 01:00:008-KStáhnout
2022-04-27 00:00:008-KStáhnout
2022-04-01 01:00:008-KStáhnout
2022-04-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2022-02-25 00:00:008-KStáhnout
2022-02-24 23:00:008-KStáhnout
2022-02-11 00:00:008-KStáhnout
2022-02-10 23:00:008-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-12-15 00:00:008-KStáhnout
2021-12-14 23:00:008-KStáhnout
2021-11-24 00:00:008-KStáhnout
2021-11-23 23:00:008-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-10-07 01:00:008-KStáhnout
2021-10-07 00:00:008-KStáhnout
2021-09-13 01:00:008-KStáhnout
2021-09-13 00:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 00:00:008-KStáhnout
2021-07-06 01:00:008-KStáhnout
2021-07-06 00:00:008-KStáhnout
2021-06-25 01:00:008-KStáhnout
2021-06-25 00:00:008-KStáhnout
2021-06-23 01:00:008-KStáhnout
2021-06-23 00:00:008-KStáhnout
2021-06-14 01:00:008-KStáhnout
2021-06-14 00:00:008-KStáhnout
2021-06-04 01:00:008-KStáhnout
2021-06-04 00:00:008-KStáhnout
2021-05-19 01:00:008-KStáhnout
2021-05-19 00:00:008-KStáhnout
2021-05-13 01:00:008-KStáhnout
2021-05-13 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-04-27 01:00:008-KStáhnout
2021-04-27 00:00:008-KStáhnout
2021-04-20 01:00:008-KStáhnout
2021-04-20 00:00:008-KStáhnout
2021-04-12 01:00:008-KStáhnout
2021-04-12 00:00:008-KStáhnout
2021-03-01 00:00:0010-KStáhnout
2021-02-28 23:00:0010-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-22 00:00:008-KStáhnout
2021-02-21 23:00:008-KStáhnout
2021-02-19 00:00:008-KStáhnout
2021-02-18 23:00:008-KStáhnout
2021-01-22 00:00:008-KStáhnout
2021-01-21 23:00:008-KStáhnout
2020-12-28 00:00:008-KStáhnout
2020-12-27 23:00:008-KStáhnout
2020-12-22 00:00:008-KStáhnout
2020-12-21 23:00:008-KStáhnout
2020-12-18 00:00:008-KStáhnout
2020-12-17 23:00:008-KStáhnout
2020-12-16 00:00:008-KStáhnout
2020-12-15 23:00:008-KStáhnout
2020-12-09 00:00:008-KStáhnout
2020-12-08 23:00:008-KStáhnout
2020-12-04 00:00:008-KStáhnout
2020-12-03 23:00:008-KStáhnout
2020-11-25 00:00:008-KStáhnout
2020-11-24 23:00:008-KStáhnout
2020-11-19 00:00:008-KStáhnout
2020-11-18 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-10-26 00:00:008-KStáhnout
2020-10-25 23:00:008-KStáhnout
2020-10-16 01:00:008-KStáhnout
2020-10-16 00:00:008-KStáhnout
2020-10-14 01:00:008-KStáhnout
2020-10-14 00:00:008-KStáhnout
2020-10-08 01:00:008-KStáhnout
2020-10-08 00:00:008-KStáhnout
2020-10-07 01:00:008-KStáhnout
2020-10-07 00:00:008-KStáhnout
2020-10-06 01:00:008-KStáhnout
2020-10-06 00:00:008-KStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-07-14 01:00:008-KStáhnout
2020-07-14 00:00:008-KStáhnout
2020-06-30 01:00:008-KStáhnout
2020-06-30 00:00:008-KStáhnout
2020-06-12 01:00:008-KStáhnout
2020-06-12 00:00:008-KStáhnout
2020-06-02 01:00:008-KStáhnout
2020-06-02 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-04-24 01:00:008-KStáhnout
2020-04-24 00:00:008-KStáhnout
2020-04-21 01:00:008-KStáhnout
2020-04-21 00:00:008-KStáhnout
2020-04-15 01:00:008-KStáhnout
2020-04-15 00:00:008-KStáhnout
2020-04-01 01:00:008-KStáhnout
2020-04-01 00:00:008-KStáhnout
2020-03-12 00:00:008-KStáhnout
2020-03-12 00:00:0010-KStáhnout
2020-03-11 23:00:008-KStáhnout
2020-03-11 23:00:0010-KStáhnout
2020-02-26 00:00:008-KStáhnout
2020-02-25 23:00:008-KStáhnout
2019-12-19 00:00:008-KStáhnout
2019-12-18 23:00:008-KStáhnout
2019-12-12 00:00:008-KStáhnout
2019-12-11 23:00:008-KStáhnout
2019-12-11 00:00:008-KStáhnout
2019-12-10 23:00:008-KStáhnout
2019-12-05 00:00:008-KStáhnout
2019-12-04 23:00:008-KStáhnout
2019-11-29 00:00:008-KStáhnout
2019-11-28 23:00:008-KStáhnout
2019-11-15 00:00:008-KStáhnout
2019-11-14 23:00:008-KStáhnout
2019-11-13 00:00:008-KStáhnout
2019-11-13 00:00:0010-QStáhnout
2019-11-12 23:00:008-KStáhnout
2019-11-12 23:00:0010-QStáhnout
2019-11-01 00:00:008-KStáhnout
2019-10-31 23:00:008-KStáhnout
2019-10-31 00:00:008-KStáhnout
2019-10-30 23:00:008-KStáhnout
2019-10-28 00:00:008-KStáhnout
2019-10-27 23:00:008-KStáhnout
2019-10-25 01:00:008-KStáhnout
2019-10-25 00:00:008-KStáhnout
2019-09-19 01:00:008-KStáhnout
2019-09-19 00:00:008-KStáhnout
2019-08-30 01:00:008-KStáhnout
2019-08-30 00:00:008-KStáhnout
2019-08-14 01:00:008-KStáhnout
2019-08-14 01:00:0010-QStáhnout
2019-08-14 00:00:008-KStáhnout
2019-08-14 00:00:0010-QStáhnout
2019-07-08 01:00:008-KStáhnout
2019-07-08 00:00:008-KStáhnout
2019-07-01 01:00:008-KStáhnout
2019-07-01 00:00:008-KStáhnout
2019-06-26 01:00:008-KStáhnout
2019-06-26 00:00:008-KStáhnout
2019-06-06 01:00:008-KStáhnout
2019-06-06 00:00:008-KStáhnout
2019-05-15 01:00:008-KStáhnout
2019-05-15 00:00:008-KStáhnout
2019-05-14 01:00:008-KStáhnout
2019-05-14 00:00:008-KStáhnout
2019-05-10 01:00:008-KStáhnout
2019-05-10 01:00:0010-QStáhnout
2019-05-10 00:00:008-KStáhnout
2019-05-10 00:00:0010-QStáhnout
2019-04-30 01:00:008-KStáhnout
2019-04-30 00:00:008-KStáhnout
2019-03-22 00:00:008-KStáhnout
2019-03-22 00:00:0010-KStáhnout
2019-03-21 23:00:008-KStáhnout
2019-03-21 23:00:0010-KStáhnout
2019-03-12 00:00:008-KStáhnout
2019-03-11 23:00:008-KStáhnout
2019-01-14 00:00:008-KStáhnout
2019-01-13 23:00:008-KStáhnout
2018-12-11 00:00:008-KStáhnout
2018-12-10 23:00:008-KStáhnout
2018-11-13 00:00:008-KStáhnout
2018-11-13 00:00:0010-QStáhnout
2018-11-12 23:00:008-KStáhnout
2018-11-12 23:00:0010-QStáhnout
2018-11-01 00:00:008-KStáhnout
2018-10-31 23:00:008-KStáhnout
2018-10-23 01:00:008-KStáhnout
2018-10-23 00:00:008-KStáhnout
2018-09-26 01:00:008-KStáhnout
2018-09-26 00:00:008-KStáhnout
preloader